From: Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease
Treatment | Total Force (N) | Physiological Force (N) | Stiffness (N/m × 103) | Size Independent Stiffness (N/m2) | Von Mises Stress (MPa) |
---|---|---|---|---|---|
0 IF Placebo | 272.51 ± 33.62a | 81.75 ± 10.09a | 435.24 ± 52.46a | 309.18 ± 36.02a | 15.49 ± 1.41a |
0 IF LPS | 173.95 ± 56.94b | 52.19 ± 17.08b | 277.19 ± 90.74b | 183.87 ± 58.53b | 35.94 ± 10.22b |
126 IF Placebo | 272.43 ± 68.25a | 81.73 ± 20.47a | 432.74 ± 107.88a | 299.34 ± 72.88a | 25.75 ± 9.86a |
126 IF LPS | 111.29 ± 16.51b | 33.39 ± 5.00b | 177.58 ± 26.20b | 128.93 ± 21.01b | 32.19 ± 5.46b |
504 IF Placebo | 205.29 ± 40.16a | 61.59 ± 12.05a | 327.76 ± 64.41a | 235.51 ± 46.35a | 26.54 ± 8.11a |
504 IF LPS | 214.20 ± 65.75b | 64.26 ± 17.73b | 340.86 ± 104.08b | 251.69 ± 78.52b | 29.92 ± 7.83b |
P-values | Â | Â | Â | Â | Â |
LPS | 0.0500 | 0.0500 | 0.0487 | 0.0500 | 0.1617 |
IF | 0.8232 | 0.8232 | 0.8144 | 0.8148 | 0.8431 |
LPS*IF | 0.2475 | 0.2475 | 0.2497 | 0.2388 | 0.9095 |